Mark Jeffrey DeLong

Chief Business & Strat Officer at Apellis Pharmaceuticals · 5 reported transactions in 1 company · latest trade Feb 11, 2026

Their trades


Apellis PharmaceuticalsAPLS	Sold $8.2K · 368 shares	Feb 11, 2026
Apellis PharmaceuticalsAPLS	Sold $73.4K · 3,371 shares	Jan 22, 2026
Apellis PharmaceuticalsAPLS	Sold $26.4K · 1,334 shares	Jan 20, 2026
Apellis PharmaceuticalsAPLS	Sold $39.5K · 1,780 shares	Jan 13, 2026

Feb 11, 2026 · APLS

$8.2K

Jan 22, 2026 · APLS

$73.4K

Jan 20, 2026 · APLS

$26.4K

Jan 13, 2026 · APLS

$39.5K

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Business & Strat Officer at Apellis Pharmaceuticals · 5 reported transactions in 1 company · latest trade Feb 11, 2026


Apellis PharmaceuticalsAPLS	Sold $8.2K · 368 shares	Feb 11, 2026
Apellis PharmaceuticalsAPLS	Sold $73.4K · 3,371 shares	Jan 22, 2026
Apellis PharmaceuticalsAPLS	Sold $26.4K · 1,334 shares	Jan 20, 2026
Apellis PharmaceuticalsAPLS	Sold $39.5K · 1,780 shares	Jan 13, 2026